

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 7.63732768 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.80193020 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.80193020 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.61859969 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.61859969 |
| 6 | amino acid salvage (GO:0043102) | 6.40661947 |
| 7 | L-methionine salvage (GO:0071267) | 6.40661947 |
| 8 | L-methionine biosynthetic process (GO:0071265) | 6.40661947 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.02454844 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.60164249 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 5.48913932 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.39747568 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.39747568 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.39747568 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.36392525 |
| 16 | cysteine metabolic process (GO:0006534) | 5.31546345 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.25014824 |
| 18 | lysine metabolic process (GO:0006553) | 5.23175696 |
| 19 | lysine catabolic process (GO:0006554) | 5.23175696 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.19194479 |
| 21 | methionine biosynthetic process (GO:0009086) | 5.15898715 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.15470133 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.12423065 |
| 24 | cellular ketone body metabolic process (GO:0046950) | 5.11203437 |
| 25 | CENP-A containing nucleosome assembly (GO:0034080) | 5.06944063 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.91979990 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86031728 |
| 28 | chromatin remodeling at centromere (GO:0031055) | 4.85778168 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.83716985 |
| 30 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.74404770 |
| 31 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.74404770 |
| 32 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.74404770 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.72770240 |
| 34 | methionine metabolic process (GO:0006555) | 4.70099989 |
| 35 | urea cycle (GO:0000050) | 4.64055478 |
| 36 | urea metabolic process (GO:0019627) | 4.64055478 |
| 37 | sulfur amino acid biosynthetic process (GO:0000097) | 4.63621154 |
| 38 | ethanol oxidation (GO:0006069) | 4.57305421 |
| 39 | regulation of translation in response to stress (GO:0043555) | 4.56625119 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54986561 |
| 41 | protein carboxylation (GO:0018214) | 4.54986561 |
| 42 | * alpha-amino acid catabolic process (GO:1901606) | 4.51012640 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.47986690 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 4.47955060 |
| 45 | regulation of protein activation cascade (GO:2000257) | 4.47738535 |
| 46 | glycine metabolic process (GO:0006544) | 4.46811269 |
| 47 | complement activation, alternative pathway (GO:0006957) | 4.43764725 |
| 48 | ketone body metabolic process (GO:1902224) | 4.41353537 |
| 49 | regulation of sister chromatid cohesion (GO:0007063) | 4.40045422 |
| 50 | bile acid metabolic process (GO:0008206) | 4.37651128 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 4.36358407 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.36066886 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.36021870 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.33627784 |
| 55 | * cellular amino acid catabolic process (GO:0009063) | 4.33387418 |
| 56 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.30124324 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 4.29223773 |
| 58 | detection of calcium ion (GO:0005513) | 4.27802312 |
| 59 | fatty acid beta-oxidation (GO:0006635) | 4.24546816 |
| 60 | regulation of complement activation (GO:0030449) | 4.23385463 |
| 61 | * branched-chain amino acid catabolic process (GO:0009083) | 4.21360548 |
| 62 | * valine metabolic process (GO:0006573) | 4.21139842 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 4.18964281 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.15803221 |
| 65 | cellular glucuronidation (GO:0052695) | 4.12928257 |
| 66 | tyrosine metabolic process (GO:0006570) | 4.12322909 |
| 67 | fatty acid oxidation (GO:0019395) | 4.12152037 |
| 68 | aspartate family amino acid biosynthetic process (GO:0009067) | 4.10501881 |
| 69 | regulation of fibrinolysis (GO:0051917) | 4.09226381 |
| 70 | aspartate family amino acid catabolic process (GO:0009068) | 4.06252025 |
| 71 | lipid oxidation (GO:0034440) | 4.04598510 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 4.04418630 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03273896 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.99359170 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.99359170 |
| 76 | * carboxylic acid catabolic process (GO:0046395) | 3.97828838 |
| 77 | * organic acid catabolic process (GO:0016054) | 3.97828838 |
| 78 | fatty acid catabolic process (GO:0009062) | 3.97529268 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.96440349 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 3.95454638 |
| 81 | macromolecular complex remodeling (GO:0034367) | 3.95454638 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 3.95454638 |
| 83 | monocarboxylic acid catabolic process (GO:0072329) | 3.89465164 |
| 84 | * branched-chain amino acid metabolic process (GO:0009081) | 3.89070425 |
| 85 | carnitine metabolic process (GO:0009437) | 3.88706932 |
| 86 | histone exchange (GO:0043486) | 3.88526600 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.87828089 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.87156267 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.87076777 |
| 90 | cellular biogenic amine catabolic process (GO:0042402) | 3.86858915 |
| 91 | amine catabolic process (GO:0009310) | 3.86858915 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.86032595 |
| 93 | sulfur amino acid metabolic process (GO:0000096) | 3.85927832 |
| 94 | bile acid and bile salt transport (GO:0015721) | 3.80474067 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.78894133 |
| 96 | glutamate metabolic process (GO:0006536) | 3.78763286 |
| 97 | glucuronate metabolic process (GO:0019585) | 3.77314542 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.77314542 |
| 99 | imidazole-containing compound metabolic process (GO:0052803) | 3.71541203 |
| 100 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.70068904 |
| 101 | mitochondrion transport along microtubule (GO:0047497) | 3.70068904 |
| 102 | DNA replication-independent nucleosome organization (GO:0034724) | 3.68575997 |
| 103 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.68575997 |
| 104 | plasma lipoprotein particle clearance (GO:0034381) | 3.68388520 |
| 105 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.67729840 |
| 106 | negative regulation of cholesterol transport (GO:0032375) | 3.67099011 |
| 107 | negative regulation of sterol transport (GO:0032372) | 3.67099011 |
| 108 | establishment of mitochondrion localization (GO:0051654) | 3.65557434 |
| 109 | iron-sulfur cluster assembly (GO:0016226) | 3.65335385 |
| 110 | metallo-sulfur cluster assembly (GO:0031163) | 3.65335385 |
| 111 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.63092220 |
| 112 | drug catabolic process (GO:0042737) | 3.60837886 |
| 113 | drug transmembrane transport (GO:0006855) | 3.57084992 |
| 114 | phospholipid efflux (GO:0033700) | 3.53838169 |
| 115 | urate metabolic process (GO:0046415) | 3.52325876 |
| 116 | ethanol metabolic process (GO:0006067) | 3.50259327 |
| 117 | N-terminal protein amino acid acetylation (GO:0006474) | 3.50234596 |
| 118 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.50086619 |
| 119 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.50086619 |
| 120 | ubiquinone metabolic process (GO:0006743) | 3.47232726 |
| 121 | drug metabolic process (GO:0017144) | 3.45149157 |
| 122 | ubiquinone biosynthetic process (GO:0006744) | 3.45086016 |
| 123 | establishment of integrated proviral latency (GO:0075713) | 3.44143002 |
| 124 | biotin metabolic process (GO:0006768) | 3.42907597 |
| 125 | mitotic sister chromatid cohesion (GO:0007064) | 3.42562194 |
| 126 | phospholipid homeostasis (GO:0055091) | 3.42227964 |
| 127 | * small molecule catabolic process (GO:0044282) | 3.39470984 |
| 128 | DNA integration (GO:0015074) | 3.39409427 |
| 129 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38852378 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.37605789 |
| 131 | L-serine metabolic process (GO:0006563) | 3.37149877 |
| 132 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36332824 |
| 133 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36332824 |
| 134 | primary alcohol catabolic process (GO:0034310) | 3.35676618 |
| 135 | flavonoid metabolic process (GO:0009812) | 3.35313151 |
| 136 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.33109304 |
| 137 | histone H4-K5 acetylation (GO:0043981) | 3.30740642 |
| 138 | histone H4-K8 acetylation (GO:0043982) | 3.30740642 |
| 139 | histone H4-K12 acetylation (GO:0043983) | 3.15319610 |
| 140 | fatty acid elongation (GO:0030497) | 3.13231280 |
| 141 | mitotic metaphase plate congression (GO:0007080) | 3.11866093 |
| 142 | DNA ligation (GO:0006266) | 3.07989719 |
| 143 | regulation of gene silencing by RNA (GO:0060966) | 3.04741428 |
| 144 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.04741428 |
| 145 | regulation of gene silencing by miRNA (GO:0060964) | 3.04741428 |
| 146 | negative regulation of translational initiation (GO:0045947) | 3.03245319 |
| 147 | aspartate family amino acid metabolic process (GO:0009066) | 3.01980622 |
| 148 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.97330722 |
| 149 | seminiferous tubule development (GO:0072520) | 2.94324231 |
| 150 | neuronal action potential (GO:0019228) | 2.93146320 |
| 151 | positive regulation of microtubule polymerization (GO:0031116) | 2.91905646 |
| 152 | quinone biosynthetic process (GO:1901663) | 2.89858343 |
| 153 | establishment of viral latency (GO:0019043) | 2.89815510 |
| 154 | histone arginine methylation (GO:0034969) | 2.89200067 |
| 155 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.87471772 |
| 156 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.84976096 |
| 157 | telomere maintenance via telomere lengthening (GO:0010833) | 2.82575105 |
| 158 | maturation of 5.8S rRNA (GO:0000460) | 2.79715001 |
| 159 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72699880 |
| 160 | postsynaptic membrane organization (GO:0001941) | 2.70571722 |
| 161 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.69237572 |
| 162 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.69237572 |
| 163 | regulation of centriole replication (GO:0046599) | 2.68005348 |
| 164 | microtubule nucleation (GO:0007020) | 2.63455785 |
| 165 | cardiolipin metabolic process (GO:0032048) | 2.62302941 |
| 166 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.58232758 |
| 167 | signal peptide processing (GO:0006465) | 2.58020351 |
| 168 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.54795806 |
| 169 | germ cell migration (GO:0008354) | 2.54153798 |
| 170 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.54053807 |
| 171 | cellular response to cholesterol (GO:0071397) | 2.53752939 |
| 172 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.51829137 |
| 173 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.49881490 |
| 174 | purine nucleobase biosynthetic process (GO:0009113) | 2.49636832 |
| 175 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.49104642 |
| 176 | peptidyl-cysteine modification (GO:0018198) | 2.48974393 |
| 177 | mitotic chromosome condensation (GO:0007076) | 2.48335007 |
| 178 | IMP biosynthetic process (GO:0006188) | 2.46623745 |
| 179 | adaptation of signaling pathway (GO:0023058) | 2.46576900 |
| 180 | C4-dicarboxylate transport (GO:0015740) | 2.46325202 |
| 181 | oxidative phosphorylation (GO:0006119) | 2.46156225 |
| 182 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.45382704 |
| 183 | isoprenoid biosynthetic process (GO:0008299) | 2.42856801 |
| 184 | secondary heart field specification (GO:0003139) | 2.39979846 |
| 185 | heart field specification (GO:0003128) | 2.39979846 |
| 186 | chromatin assembly or disassembly (GO:0006333) | 2.39700846 |
| 187 | negative regulation of telomere maintenance (GO:0032205) | 2.36293820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.57264257 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.68235553 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.61041477 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.78677180 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77700074 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.45064565 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.75683312 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71630011 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.44759694 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.08454748 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67791678 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.44075719 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.07167208 |
| 14 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.76160630 |
| 15 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62259954 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.50299930 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47892120 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.37465247 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.37219821 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.32304721 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27706661 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24147981 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20798650 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.19649023 |
| 25 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.19402041 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17784311 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17640173 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.07652574 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05043731 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8840597 |
| 31 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.97042924 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94562563 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.83631700 |
| 34 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.81426116 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81305192 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79458794 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66128255 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63569240 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59554992 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55241686 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54142480 |
| 42 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49388373 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47992204 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42909204 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.42068713 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40170041 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40069568 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38871654 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38086948 |
| 50 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.36559971 |
| 51 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34850351 |
| 52 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34665053 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33112786 |
| 54 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.32515090 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31882597 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.31692940 |
| 57 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30748470 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28302860 |
| 59 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27518516 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27071640 |
| 61 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.26725567 |
| 62 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26041581 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24984103 |
| 64 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24815014 |
| 65 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24395008 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23710715 |
| 67 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.20482187 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.19487894 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19440937 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.17521458 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16798099 |
| 72 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.16536778 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13807647 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13401891 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12955172 |
| 76 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11598593 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11427796 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10477380 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09914765 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09863123 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07994068 |
| 82 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07612598 |
| 83 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05016543 |
| 84 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04844335 |
| 85 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02568172 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01179823 |
| 87 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.00354073 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99803419 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99038680 |
| 90 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.95344353 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92733762 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92697755 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91154217 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90895162 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90740755 |
| 96 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.90067477 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89875918 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88110525 |
| 99 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.87945838 |
| 100 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.87913256 |
| 101 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.83358795 |
| 102 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.83358795 |
| 103 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.83358795 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.83208808 |
| 105 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82445142 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81397068 |
| 107 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.80935073 |
| 108 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.80786390 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80465857 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80418770 |
| 111 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.79993765 |
| 112 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79898526 |
| 113 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.79056248 |
| 114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78623039 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78169314 |
| 116 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77108036 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77084713 |
| 118 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.76699865 |
| 119 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.75328367 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74839443 |
| 121 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74732307 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73548007 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73304001 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72827863 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72656179 |
| 126 | ERA_21632823_ChIP-Seq_H3396_Human | 0.72610294 |
| 127 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.72497231 |
| 128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71795040 |
| 129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71319490 |
| 130 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.71312291 |
| 131 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.70748276 |
| 132 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.69976475 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69920962 |
| 134 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.69906773 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69460236 |
| 136 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.68931913 |
| 137 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68200063 |
| 138 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.66287707 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65383119 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62898408 |
| 141 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62597564 |
| 142 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59149995 |
| 143 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.58960523 |
| 144 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58518583 |
| 145 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.57910269 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56997340 |
| 147 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.56494532 |
| 148 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55977277 |
| 149 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.55478514 |
| 150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.54465793 |
| 151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54451805 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.54274141 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.54274141 |
| 154 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53878508 |
| 155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.53660999 |
| 156 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.53446925 |
| 157 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.53097282 |
| 158 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.52480120 |
| 159 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51712868 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51442389 |
| 161 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.49602481 |
| 162 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.49602481 |
| 163 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49414611 |
| 164 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49319436 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49168249 |
| 166 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.49008543 |
| 167 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.48928856 |
| 168 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48315202 |
| 169 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.48198997 |
| 170 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47402342 |
| 171 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47056112 |
| 172 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46936712 |
| 173 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.46617798 |
| 174 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.46533284 |
| 175 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46141569 |
| 176 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.45952690 |
| 177 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45655487 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.44466513 |
| 179 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.43917564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.58275162 |
| 2 | MP0005360_urolithiasis | 6.95945430 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.76400166 |
| 4 | MP0005365_abnormal_bile_salt | 5.75909736 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03091407 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.59819487 |
| 7 | MP0008877_abnormal_DNA_methylation | 4.07965387 |
| 8 | MP0002736_abnormal_nociception_after | 3.39488768 |
| 9 | MP0003252_abnormal_bile_duct | 3.33898963 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.31253724 |
| 11 | MP0005332_abnormal_amino_acid | 3.24601195 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.20006311 |
| 13 | MP0009840_abnormal_foam_cell | 3.12883793 |
| 14 | MP0001188_hyperpigmentation | 2.86837207 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.83575633 |
| 16 | MP0008058_abnormal_DNA_repair | 2.83284451 |
| 17 | MP0003195_calcinosis | 2.74169636 |
| 18 | MP0005083_abnormal_biliary_tract | 2.69958012 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.64378998 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.59223237 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.48993894 |
| 22 | MP0000751_myopathy | 2.38659160 |
| 23 | MP0001529_abnormal_vocalization | 2.18635731 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.16399463 |
| 25 | MP0000609_abnormal_liver_physiology | 2.01792388 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.94428629 |
| 27 | MP0001764_abnormal_homeostasis | 1.87230707 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.83337274 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.79177306 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.79177306 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.79105365 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.76626028 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.74311677 |
| 34 | MP0004147_increased_porphyrin_level | 1.72526273 |
| 35 | MP0003186_abnormal_redox_activity | 1.67900127 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.67404651 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.66895537 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.64448163 |
| 39 | MP0003868_abnormal_feces_composition | 1.62320394 |
| 40 | MP0001486_abnormal_startle_reflex | 1.58252659 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.56279674 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.56117455 |
| 43 | MP0005670_abnormal_white_adipose | 1.50846475 |
| 44 | MP0009046_muscle_twitch | 1.49932376 |
| 45 | MP0003880_abnormal_central_pattern | 1.44880125 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.43862130 |
| 47 | MP0009697_abnormal_copulation | 1.42524460 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.42493354 |
| 49 | MP0004043_abnormal_pH_regulation | 1.35355923 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.34816670 |
| 51 | MP0002272_abnormal_nervous_system | 1.31278066 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.30887253 |
| 53 | MP0003787_abnormal_imprinting | 1.30625543 |
| 54 | MP0004130_abnormal_muscle_cell | 1.29948551 |
| 55 | MP0003635_abnormal_synaptic_transmissio | 1.29269224 |
| 56 | MP0009745_abnormal_behavioral_response | 1.27379055 |
| 57 | MP0003828_pulmonary_edema | 1.25932631 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.25241094 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.24490816 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.23205276 |
| 61 | MP0003890_abnormal_embryonic-extraembry | 1.22991392 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.22648189 |
| 63 | MP0005451_abnormal_body_composition | 1.21778537 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.21548790 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.20280743 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.14836590 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.13850893 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.13036485 |
| 69 | MP0000598_abnormal_liver_morphology | 1.12525492 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 1.12512650 |
| 71 | MP0003011_delayed_dark_adaptation | 1.12432121 |
| 72 | MP0003941_abnormal_skin_development | 1.08136612 |
| 73 | MP0001984_abnormal_olfaction | 1.06592907 |
| 74 | MP0002063_abnormal_learning/memory/cond | 1.03877248 |
| 75 | MP0001756_abnormal_urination | 1.03065721 |
| 76 | MP0004859_abnormal_synaptic_plasticity | 1.01997393 |
| 77 | MP0010094_abnormal_chromosome_stability | 1.01941877 |
| 78 | MP0002064_seizures | 0.99130310 |
| 79 | MP0009764_decreased_sensitivity_to | 0.97451363 |
| 80 | MP0001970_abnormal_pain_threshold | 0.97444921 |
| 81 | MP0000516_abnormal_urinary_system | 0.97307167 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 0.97307167 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.96965065 |
| 84 | MP0002106_abnormal_muscle_physiology | 0.96179610 |
| 85 | MP0000604_amyloidosis | 0.95320885 |
| 86 | MP0002971_abnormal_brown_adipose | 0.95229810 |
| 87 | MP0003136_yellow_coat_color | 0.94221183 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.93879976 |
| 89 | MP0008569_lethality_at_weaning | 0.92415619 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.91648357 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.89946197 |
| 92 | MP0009703_decreased_birth_body | 0.89911633 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.89871290 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.89852577 |
| 95 | MP0009763_increased_sensitivity_to | 0.89644535 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.88501101 |
| 97 | MP0001346_abnormal_lacrimal_gland | 0.88461606 |
| 98 | MP0003119_abnormal_digestive_system | 0.87935071 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.87841088 |
| 100 | MP0005647_abnormal_sex_gland | 0.87322691 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.86837040 |
| 102 | MP0005266_abnormal_metabolism | 0.85949376 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.85720541 |
| 104 | MP0008995_early_reproductive_senescence | 0.84245846 |
| 105 | MP0005408_hypopigmentation | 0.84158098 |
| 106 | MP0005535_abnormal_body_temperature | 0.83773325 |
| 107 | MP0001661_extended_life_span | 0.83581790 |
| 108 | MP0002067_abnormal_sensory_capabilities | 0.82350971 |
| 109 | MP0003329_amyloid_beta_deposits | 0.81538814 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.80890087 |
| 111 | MP0005499_abnormal_olfactory_system | 0.80387912 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.80387912 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.80087886 |
| 114 | MP0001177_atelectasis | 0.79697935 |
| 115 | MP0008469_abnormal_protein_level | 0.79546599 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.79177788 |
| 117 | MP0003878_abnormal_ear_physiology | 0.78310519 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.78310519 |
| 119 | MP0005330_cardiomyopathy | 0.78274651 |
| 120 | MP0003690_abnormal_glial_cell | 0.78063732 |
| 121 | MP0003698_abnormal_male_reproductive | 0.77731103 |
| 122 | MP0004924_abnormal_behavior | 0.76250712 |
| 123 | MP0005386_behavior/neurological_phenoty | 0.76250712 |
| 124 | MP0005334_abnormal_fat_pad | 0.76067152 |
| 125 | MP0003111_abnormal_nucleus_morphology | 0.75103843 |
| 126 | MP0003121_genomic_imprinting | 0.74674198 |
| 127 | MP0003705_abnormal_hypodermis_morpholog | 0.74202758 |
| 128 | MP0005369_muscle_phenotype | 0.72121031 |
| 129 | MP0005423_abnormal_somatic_nervous | 0.72051843 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.71792013 |
| 131 | MP0002210_abnormal_sex_determination | 0.71726383 |
| 132 | MP0002254_reproductive_system_inflammat | 0.71287157 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.70402033 |
| 134 | MP0001501_abnormal_sleep_pattern | 0.70320032 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.69296176 |
| 136 | MP0002229_neurodegeneration | 0.68658802 |
| 137 | MP0002277_abnormal_respiratory_mucosa | 0.68542444 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.68412717 |
| 139 | MP0003646_muscle_fatigue | 0.68394281 |
| 140 | MP0001929_abnormal_gametogenesis | 0.67983370 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67628698 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.66925706 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.64629792 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.63228013 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.63029615 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.61655813 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.61253422 |
| 148 | MP0002796_impaired_skin_barrier | 0.60983924 |
| 149 | MP0002269_muscular_atrophy | 0.58175428 |
| 150 | MP0004036_abnormal_muscle_relaxation | 0.56701456 |
| 151 | MP0009053_abnormal_anal_canal | 0.56579654 |
| 152 | MP0005448_abnormal_energy_balance | 0.50907794 |
| 153 | MP0003953_abnormal_hormone_level | 0.49441161 |
| 154 | MP0003718_maternal_effect | 0.49170186 |
| 155 | MP0000747_muscle_weakness | 0.44484978 |
| 156 | MP0005395_other_phenotype | 0.44355710 |
| 157 | MP0000749_muscle_degeneration | 0.44330152 |
| 158 | MP0005166_decreased_susceptibility_to | 0.42033433 |
| 159 | MP0002970_abnormal_white_adipose | 0.41639235 |
| 160 | MP0008004_abnormal_stomach_pH | 0.41628685 |
| 161 | MP0005165_increased_susceptibility_to | 0.41451796 |
| 162 | MP0006138_congestive_heart_failure | 0.40175306 |
| 163 | MP0008872_abnormal_physiological_respon | 0.39236599 |
| 164 | MP0008873_increased_physiological_sensi | 0.39218417 |
| 165 | MP0004084_abnormal_cardiac_muscle | 0.39191465 |
| 166 | MP0004264_abnormal_extraembryonic_tissu | 0.38336043 |
| 167 | MP0005375_adipose_tissue_phenotype | 0.38177405 |
| 168 | MP0003959_abnormal_lean_body | 0.36223460 |
| 169 | MP0000639_abnormal_adrenal_gland | 0.36089443 |
| 170 | MP0009115_abnormal_fat_cell | 0.35821315 |
| 171 | MP0001853_heart_inflammation | 0.34195187 |
| 172 | MP0003724_increased_susceptibility_to | 0.33290561 |
| 173 | MP0004782_abnormal_surfactant_physiolog | 0.33287736 |
| 174 | MP0009672_abnormal_birth_weight | 0.32405182 |
| 175 | MP0000249_abnormal_blood_vessel | 0.32348454 |
| 176 | MP0002822_catalepsy | 0.31883997 |
| 177 | MP0004087_abnormal_muscle_fiber | 0.31512830 |
| 178 | MP0001544_abnormal_cardiovascular_syste | 0.29706607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.21872201 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.01677227 |
| 3 | Focal motor seizures (HP:0011153) | 5.71774932 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.48431537 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.48028767 |
| 6 | Xanthomatosis (HP:0000991) | 5.32847333 |
| 7 | Hyperglycinuria (HP:0003108) | 5.13657752 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.98822120 |
| 9 | Hyperglycinemia (HP:0002154) | 4.96432961 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.87282202 |
| 11 | Hyperammonemia (HP:0001987) | 4.82089507 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.81806925 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.81806925 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.77379349 |
| 15 | Personality changes (HP:0000751) | 4.62593086 |
| 16 | * Abnormality of fatty-acid metabolism (HP:0004359) | 4.58637103 |
| 17 | Acanthocytosis (HP:0001927) | 4.54550216 |
| 18 | Cerebral hypomyelination (HP:0006808) | 4.47832479 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.47038600 |
| 20 | Ketosis (HP:0001946) | 4.46028041 |
| 21 | Complement deficiency (HP:0004431) | 4.18015503 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.15395186 |
| 23 | Hypolipoproteinemia (HP:0010981) | 4.04974752 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.97307383 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82604815 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.78661709 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78182042 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.78102478 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.76292801 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.74651642 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 3.69829226 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.68912763 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.68912763 |
| 34 | Ketoacidosis (HP:0001993) | 3.68462894 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.55139988 |
| 36 | Delusions (HP:0000746) | 3.54648733 |
| 37 | Fat malabsorption (HP:0002630) | 3.53870283 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49675920 |
| 39 | Joint hemorrhage (HP:0005261) | 3.39640358 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.39305610 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.36031470 |
| 42 | Epidermoid cyst (HP:0200040) | 3.32009674 |
| 43 | Lethargy (HP:0001254) | 3.24010327 |
| 44 | Self-mutilation (HP:0000742) | 3.21603316 |
| 45 | Disinhibition (HP:0000734) | 3.20784956 |
| 46 | Decreased central vision (HP:0007663) | 3.18761170 |
| 47 | Cerebral edema (HP:0002181) | 3.15062485 |
| 48 | Postnatal microcephaly (HP:0005484) | 3.14690641 |
| 49 | Gout (HP:0001997) | 3.13559412 |
| 50 | Abnormality of complement system (HP:0005339) | 3.05662284 |
| 51 | Metabolic acidosis (HP:0001942) | 3.03829829 |
| 52 | Dyskinesia (HP:0100660) | 3.03026525 |
| 53 | Pendular nystagmus (HP:0012043) | 3.01736490 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.98250698 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91739788 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90144396 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.89346699 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.88510266 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.87916208 |
| 60 | Proximal tubulopathy (HP:0000114) | 2.85562036 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.85102230 |
| 62 | Steatorrhea (HP:0002570) | 2.81876579 |
| 63 | Oligomenorrhea (HP:0000876) | 2.78612642 |
| 64 | Premature ovarian failure (HP:0008209) | 2.72589271 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.71251756 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.67074017 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.66165382 |
| 68 | Hyperalaninemia (HP:0003348) | 2.66165382 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.66165382 |
| 70 | Inappropriate behavior (HP:0000719) | 2.62596471 |
| 71 | Dialeptic seizures (HP:0011146) | 2.61547224 |
| 72 | Hepatic necrosis (HP:0002605) | 2.60638341 |
| 73 | Vomiting (HP:0002013) | 2.60628587 |
| 74 | Unsteady gait (HP:0002317) | 2.60411726 |
| 75 | Epileptic encephalopathy (HP:0200134) | 2.59801636 |
| 76 | Absence seizures (HP:0002121) | 2.58840040 |
| 77 | Glycosuria (HP:0003076) | 2.54512613 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.54512613 |
| 79 | Bile duct proliferation (HP:0001408) | 2.53914153 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 2.53914153 |
| 81 | CNS hypomyelination (HP:0003429) | 2.50443011 |
| 82 | Visual hallucinations (HP:0002367) | 2.50109761 |
| 83 | Acute hepatic failure (HP:0006554) | 2.49107726 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 2.48678321 |
| 85 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.48560619 |
| 86 | Focal seizures (HP:0007359) | 2.48442444 |
| 87 | Myoglobinuria (HP:0002913) | 2.45600908 |
| 88 | Hyperkalemia (HP:0002153) | 2.44562386 |
| 89 | Nausea (HP:0002018) | 2.41417914 |
| 90 | Renal cortical cysts (HP:0000803) | 2.38969073 |
| 91 | Acute encephalopathy (HP:0006846) | 2.37259630 |
| 92 | Vascular calcification (HP:0004934) | 2.35013085 |
| 93 | Irritability (HP:0000737) | 2.31685970 |
| 94 | Progressive inability to walk (HP:0002505) | 2.31677754 |
| 95 | Spastic diplegia (HP:0001264) | 2.31247378 |
| 96 | Malnutrition (HP:0004395) | 2.30812235 |
| 97 | Myopathic facies (HP:0002058) | 2.28953900 |
| 98 | Pancreatitis (HP:0001733) | 2.28411035 |
| 99 | Inability to walk (HP:0002540) | 2.27936597 |
| 100 | Hyperuricemia (HP:0002149) | 2.27680341 |
| 101 | Increased purine levels (HP:0004368) | 2.27680341 |
| 102 | Skin nodule (HP:0200036) | 2.27278780 |
| 103 | Abnormality of the labia minora (HP:0012880) | 2.27134780 |
| 104 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27036038 |
| 105 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.25075412 |
| 106 | Drooling (HP:0002307) | 2.22606117 |
| 107 | Hypoglycemic seizures (HP:0002173) | 2.17137368 |
| 108 | Chronic bronchitis (HP:0004469) | 2.16208753 |
| 109 | Choreoathetosis (HP:0001266) | 2.16062540 |
| 110 | Increased serum pyruvate (HP:0003542) | 2.15430609 |
| 111 | Abnormality of glycolysis (HP:0004366) | 2.15430609 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.14001191 |
| 113 | Alkalosis (HP:0001948) | 2.13357386 |
| 114 | Dry hair (HP:0011359) | 2.13235817 |
| 115 | Excessive salivation (HP:0003781) | 2.10990354 |
| 116 | Myocardial infarction (HP:0001658) | 2.10958656 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 2.10623152 |
| 118 | Late onset (HP:0003584) | 2.10561115 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.09173110 |
| 120 | Methylmalonic aciduria (HP:0012120) | 2.08699262 |
| 121 | Cardiovascular calcification (HP:0011915) | 2.08653874 |
| 122 | Opisthotonus (HP:0002179) | 2.08309641 |
| 123 | Rhabdomyolysis (HP:0003201) | 2.08258550 |
| 124 | Neonatal onset (HP:0003623) | 2.07849712 |
| 125 | Attenuation of retinal blood vessels (HP:0007843) | 2.07545389 |
| 126 | Brushfield spots (HP:0001088) | 2.06960132 |
| 127 | Exercise-induced muscle cramps (HP:0003710) | 2.06608600 |
| 128 | Atonic seizures (HP:0010819) | 2.05283951 |
| 129 | Cholelithiasis (HP:0001081) | 2.04078215 |
| 130 | Septo-optic dysplasia (HP:0100842) | 2.04077666 |
| 131 | Intellectual disability, profound (HP:0002187) | 2.03729893 |
| 132 | Hyperventilation (HP:0002883) | 2.00795186 |
| 133 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00038832 |
| 134 | Poikilocytosis (HP:0004447) | 1.97819593 |
| 135 | Psychosis (HP:0000709) | 1.97741887 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.96976794 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.96976794 |
| 138 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96286863 |
| 139 | Ankle clonus (HP:0011448) | 1.95832656 |
| 140 | Abnormality of the vocal cords (HP:0008777) | 1.95706276 |
| 141 | Systemic lupus erythematosus (HP:0002725) | 1.94615111 |
| 142 | Enlarged kidneys (HP:0000105) | 1.93144544 |
| 143 | Lissencephaly (HP:0001339) | 1.91695316 |
| 144 | Lactic acidosis (HP:0003128) | 1.90989455 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90277949 |
| 146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89073107 |
| 147 | Prostate neoplasm (HP:0100787) | 1.88771272 |
| 148 | Hyperglycemia (HP:0003074) | 1.88708524 |
| 149 | Abnormality of vitamin metabolism (HP:0100508) | 1.88305344 |
| 150 | Genital tract atresia (HP:0001827) | 1.88076490 |
| 151 | Anencephaly (HP:0002323) | 1.87990691 |
| 152 | Sensorimotor neuropathy (HP:0007141) | 1.87056304 |
| 153 | Bilateral microphthalmos (HP:0007633) | 1.86719359 |
| 154 | Memory impairment (HP:0002354) | 1.86517180 |
| 155 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.86425478 |
| 156 | Generalized tonic-clonic seizures (HP:0002069) | 1.85612313 |
| 157 | Abnormal gallbladder physiology (HP:0012438) | 1.84783096 |
| 158 | Cholecystitis (HP:0001082) | 1.84783096 |
| 159 | Constricted visual fields (HP:0001133) | 1.83900248 |
| 160 | IgM deficiency (HP:0002850) | 1.82416458 |
| 161 | Febrile seizures (HP:0002373) | 1.82207688 |
| 162 | Spontaneous abortion (HP:0005268) | 1.81586042 |
| 163 | Acute necrotizing encephalopathy (HP:0006965) | 1.81168472 |
| 164 | Symptomatic seizures (HP:0011145) | 1.81069672 |
| 165 | Abnormal hair whorl (HP:0010721) | 1.79538023 |
| 166 | Rickets (HP:0002748) | 1.77266468 |
| 167 | Elevated hepatic transaminases (HP:0002910) | 1.76326914 |
| 168 | Hepatocellular necrosis (HP:0001404) | 1.76212666 |
| 169 | Irregular epiphyses (HP:0010582) | 1.75507556 |
| 170 | Colon cancer (HP:0003003) | 1.75479276 |
| 171 | Increased serum lactate (HP:0002151) | 1.75406431 |
| 172 | Death in childhood (HP:0003819) | 1.75201884 |
| 173 | Keratoconus (HP:0000563) | 1.74548064 |
| 174 | Increased corneal curvature (HP:0100692) | 1.74548064 |
| 175 | Scanning speech (HP:0002168) | 1.73562307 |
| 176 | Chronic otitis media (HP:0000389) | 1.73522029 |
| 177 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72672486 |
| 178 | Emotional lability (HP:0000712) | 1.71628411 |
| 179 | Hemiparesis (HP:0001269) | 1.70011020 |
| 180 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.69931549 |
| 181 | True hermaphroditism (HP:0010459) | 1.68618951 |
| 182 | Muscle fiber inclusion bodies (HP:0100299) | 1.68468623 |
| 183 | Polyphagia (HP:0002591) | 1.67541459 |
| 184 | Azoospermia (HP:0000027) | 1.67366352 |
| 185 | Abnormality of lateral ventricle (HP:0030047) | 1.66914763 |
| 186 | Status epilepticus (HP:0002133) | 1.66900530 |
| 187 | Vaginal atresia (HP:0000148) | 1.66496672 |
| 188 | Abnormal spermatogenesis (HP:0008669) | 1.66054714 |
| 189 | Cellular immunodeficiency (HP:0005374) | 1.63970218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.98633411 |
| 2 | TAOK1 | 6.24495280 |
| 3 | VRK2 | 4.40891206 |
| 4 | ZAK | 4.34385940 |
| 5 | SIK1 | 3.86131968 |
| 6 | SRPK1 | 3.66275737 |
| 7 | ERN1 | 3.51679741 |
| 8 | VRK1 | 3.21023561 |
| 9 | FGFR4 | 3.18894537 |
| 10 | CDC7 | 2.84827700 |
| 11 | TSSK6 | 2.57210567 |
| 12 | MST1R | 2.46666918 |
| 13 | PDK3 | 2.44507145 |
| 14 | PDK4 | 2.44507145 |
| 15 | PDK2 | 2.42201413 |
| 16 | MAPK13 | 2.11193067 |
| 17 | TIE1 | 2.10160705 |
| 18 | CDK19 | 2.02858555 |
| 19 | MAP2K4 | 1.98352870 |
| 20 | MKNK2 | 1.90590975 |
| 21 | INSRR | 1.87452159 |
| 22 | BMPR1B | 1.85292145 |
| 23 | NEK9 | 1.84844173 |
| 24 | MYLK | 1.81127964 |
| 25 | MKNK1 | 1.78063257 |
| 26 | PIK3CG | 1.77327799 |
| 27 | WNK4 | 1.76591215 |
| 28 | PKN2 | 1.66316538 |
| 29 | TTK | 1.59385537 |
| 30 | STK38L | 1.52250792 |
| 31 | MAP3K3 | 1.52121696 |
| 32 | FLT3 | 1.49454659 |
| 33 | RIPK4 | 1.47571168 |
| 34 | TLK1 | 1.44975293 |
| 35 | MAP2K3 | 1.44704581 |
| 36 | MAPK11 | 1.44416559 |
| 37 | OBSCN | 1.40955182 |
| 38 | PINK1 | 1.40342306 |
| 39 | TRIB3 | 1.37591929 |
| 40 | ABL2 | 1.34492646 |
| 41 | PIK3CA | 1.34055675 |
| 42 | NEK1 | 1.32551457 |
| 43 | ERBB4 | 1.30939672 |
| 44 | DYRK2 | 1.28019440 |
| 45 | IRAK3 | 1.25789617 |
| 46 | STK16 | 1.23000657 |
| 47 | TTN | 1.17924378 |
| 48 | STK39 | 1.17506189 |
| 49 | OXSR1 | 1.16987431 |
| 50 | FRK | 1.14415122 |
| 51 | MAP3K4 | 1.13523902 |
| 52 | TAOK3 | 1.13474080 |
| 53 | EPHB1 | 1.12428385 |
| 54 | TYK2 | 1.07779438 |
| 55 | PLK3 | 1.06619274 |
| 56 | AKT3 | 1.06102968 |
| 57 | KDR | 1.05862237 |
| 58 | CAMK1 | 1.05666090 |
| 59 | MAP4K1 | 1.05557529 |
| 60 | ALK | 1.05335559 |
| 61 | CDK3 | 1.03965820 |
| 62 | CAMKK1 | 0.98044509 |
| 63 | STK11 | 0.93386974 |
| 64 | UHMK1 | 0.91822125 |
| 65 | PRKAA2 | 0.89974708 |
| 66 | WNK3 | 0.89599683 |
| 67 | CAMK1D | 0.88589718 |
| 68 | JAK2 | 0.88014024 |
| 69 | MET | 0.85948295 |
| 70 | LATS1 | 0.83575631 |
| 71 | NME2 | 0.82481635 |
| 72 | GRK1 | 0.80643549 |
| 73 | MAP3K7 | 0.80327285 |
| 74 | MAP2K2 | 0.78636994 |
| 75 | PTK6 | 0.78595649 |
| 76 | DAPK2 | 0.77493055 |
| 77 | EIF2AK1 | 0.77256455 |
| 78 | PKN1 | 0.76359398 |
| 79 | MAP2K1 | 0.74955513 |
| 80 | TGFBR2 | 0.73866898 |
| 81 | CAMK4 | 0.73843107 |
| 82 | CAMK2G | 0.70983732 |
| 83 | MAP2K6 | 0.70336413 |
| 84 | EIF2AK3 | 0.69156629 |
| 85 | CCNB1 | 0.68977783 |
| 86 | CDK7 | 0.68333488 |
| 87 | PRKCG | 0.67681916 |
| 88 | PLK1 | 0.67613810 |
| 89 | TNIK | 0.66542593 |
| 90 | TNK2 | 0.65197248 |
| 91 | MAP2K7 | 0.64229409 |
| 92 | MAP3K11 | 0.63882605 |
| 93 | AURKB | 0.63747481 |
| 94 | PRKCQ | 0.61423603 |
| 95 | MAPK12 | 0.60616850 |
| 96 | CSNK1D | 0.60573137 |
| 97 | TGFBR1 | 0.59998249 |
| 98 | BRSK1 | 0.59608182 |
| 99 | FGFR2 | 0.59345273 |
| 100 | GRK6 | 0.59152624 |
| 101 | CDK6 | 0.58537064 |
| 102 | BMX | 0.58140841 |
| 103 | MAPK4 | 0.57922204 |
| 104 | EPHA3 | 0.57708822 |
| 105 | PHKG1 | 0.57084478 |
| 106 | PHKG2 | 0.57084478 |
| 107 | DYRK1A | 0.57022847 |
| 108 | CSNK1G2 | 0.56467331 |
| 109 | SGK494 | 0.56270245 |
| 110 | SGK223 | 0.56270245 |
| 111 | PDPK1 | 0.55982386 |
| 112 | ERBB2 | 0.55250507 |
| 113 | SGK2 | 0.54759703 |
| 114 | JAK1 | 0.54651541 |
| 115 | PRKCE | 0.54501952 |
| 116 | PRKAA1 | 0.53796404 |
| 117 | ATR | 0.53681101 |
| 118 | PRKACA | 0.53406014 |
| 119 | MAPK15 | 0.53282003 |
| 120 | TAOK2 | 0.53177325 |
| 121 | SGK3 | 0.52952225 |
| 122 | CAMKK2 | 0.52873762 |
| 123 | MAP3K2 | 0.51847649 |
| 124 | PBK | 0.51493291 |
| 125 | DAPK1 | 0.50900151 |
| 126 | AURKA | 0.50416138 |
| 127 | PRKACG | 0.47297180 |
| 128 | CSNK1G3 | 0.45597421 |
| 129 | TESK2 | 0.45339918 |
| 130 | BRSK2 | 0.44365197 |
| 131 | CAMK2A | 0.43126534 |
| 132 | PASK | 0.40042786 |
| 133 | PRKDC | 0.39904465 |
| 134 | PRKG1 | 0.39835678 |
| 135 | ATM | 0.39016126 |
| 136 | IRAK1 | 0.38812491 |
| 137 | YES1 | 0.38548951 |
| 138 | SGK1 | 0.38022812 |
| 139 | NEK6 | 0.37621473 |
| 140 | GRK7 | 0.37532572 |
| 141 | EPHA4 | 0.36390321 |
| 142 | PRKCZ | 0.35216003 |
| 143 | MAPK7 | 0.35097207 |
| 144 | LMTK2 | 0.34788835 |
| 145 | CDK4 | 0.33347496 |
| 146 | GSK3A | 0.32362286 |
| 147 | CDK1 | 0.32330508 |
| 148 | MARK1 | 0.32267043 |
| 149 | IRAK2 | 0.32219053 |
| 150 | MINK1 | 0.31405906 |
| 151 | CDK5 | 0.29834387 |
| 152 | MAPK9 | 0.28750077 |
| 153 | CDK2 | 0.28243852 |
| 154 | NUAK1 | 0.27438568 |
| 155 | DAPK3 | 0.27227088 |
| 156 | GSK3B | 0.25853102 |
| 157 | PIM1 | 0.25150938 |
| 158 | NTRK2 | 0.24898636 |
| 159 | MAPK3 | 0.24824405 |
| 160 | PRKACB | 0.24442357 |
| 161 | PAK3 | 0.24271127 |
| 162 | NTRK3 | 0.23870163 |
| 163 | RET | 0.23451172 |
| 164 | BUB1 | 0.23199995 |
| 165 | RPS6KB2 | 0.22225388 |
| 166 | IGF1R | 0.21926194 |
| 167 | CAMK1G | 0.21297904 |
| 168 | TBK1 | 0.21003283 |
| 169 | CAMK2D | 0.18106661 |
| 170 | PRKCA | 0.17682057 |
| 171 | CSNK1G1 | 0.17675948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60477295 |
| 2 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97059014 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96711442 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.95907738 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92190386 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87835935 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74796197 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.74487780 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71855017 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64100054 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49340376 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46913477 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46622037 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44899195 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44661054 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.43284080 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.30504113 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25130981 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16532625 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13593653 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.11925381 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08137916 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03857614 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87174102 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86393574 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86177050 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84267681 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.78796645 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78183901 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73328753 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70602511 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69813564 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68045885 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67562130 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64260929 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63027743 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62242996 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60508871 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.56098890 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53442017 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.48613161 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48363705 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46870288 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42642710 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41019747 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40197999 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36426366 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32677891 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32338509 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30541027 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.28576243 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.25040532 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15760482 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.15399777 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14145294 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12565327 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12465597 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12173560 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09969965 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09237742 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08611594 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 1.02558590 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01340707 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94914591 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.94727564 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93434973 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92202846 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.90620749 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.87610012 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.87169947 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86770947 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86086851 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85787090 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85581320 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.83449655 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82898657 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78114306 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76582856 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75639689 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.75154752 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74848087 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73317703 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72914785 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72548321 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.72171339 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.71283725 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69445224 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68044688 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68026892 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64062862 |
| 91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.63497480 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60490118 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60432805 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59781100 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.59487475 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56835570 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53799571 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50288193 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49995951 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.49512597 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48560989 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.47465708 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46599362 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.45214331 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42952509 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42811169 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42224453 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40521646 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40081871 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36624595 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35594386 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35221964 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32915099 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.30308581 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24954735 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.22490075 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20104775 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19394695 |
| 119 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19390655 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.16888011 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14443279 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10601480 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10121998 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08955667 |
| 125 | Protein export_Homo sapiens_hsa03060 | 0.04122310 |
| 126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.03684013 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03626883 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01182491 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1340237 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1262354 |
| 131 | Lysosome_Homo sapiens_hsa04142 | -0.1215229 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0935408 |
| 133 | Proteasome_Homo sapiens_hsa03050 | -0.0847050 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0796565 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0770648 |
| 136 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0766021 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0616779 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0471216 |
| 139 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0371856 |

